M&A TRANSACTION · 2022
PathGroup acquired by GTCR
$1.20B· 9.2x EBITDA
Target
PathGroup
Acquirer
GTCR
Private Equity buyer
Disclosed financials at time of acquisition
Revenue
—
EBITDA
$130.0M
Deal Value
$1.20B
EV/EBITDA
9.2x
Context
This $1.20B acquisition of PathGroup by GTCR sits in the laboratory services sub-vertical. The 9.2x EBITDA multiple paid in 2022 can be compared against the population median for laboratory services transactions of similar size on our Laboratory Services valuation hub. GTCR is acquiring as a private equity buyer; see how PE acquirers typically price laboratory services businesses on our Laboratory Services PE buyer-pool page.
Source
Data sourced from Press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own laboratory services
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the PathGroup acquisition.